3 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Educational Network in Ocular Drug Delivery and Therapeutics (OcuTher)
Date du début: 1 nov. 2016, Date de fin: 31 oct. 2020,
Ocular drug development has transformed from niche area to a major field in drug development in which many companies, including European big pharma has entered recently. Ocular drug development is a unique field in terms of drug targets and end-points of activity, local drug administration routes, tissue barriers and pharmacokinetics, drug delivery and formulation challenges and local toxicity iss ...
Voir le projet
9
Participants partenaires
TERMINÉ
A “Universal” Influenza Vaccine through Synthetic, Dendritic Cell-Targeted, Self-Replicating RNA Vaccines (UniVax)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2018,
Although vaccination is the cornerstone of prophylaxis, current vaccines provide only moderate protection. Most employ inactivated or protein-based, including multimeric antigen, vaccines requiring annual updating. Their limited antigen loads provide limited capacity for inducing robust immune defences, without assurance that both humoral and cell mediated (CMI) responses, as well as durable immun ...
Voir le projet
11
Participants partenaires
TERMINÉ
Gene Activated Matrices for Bone and Cartilage Regeneration in Arthritis (GAMBA)
Date du début: 1 sept. 2010, Date de fin: 31 août 2013,
This consortium develops a novel gene-activated matrix platform for bone and cartilage repair with a focus on osteoarthritis-related tissue damage. The S&T objectives of this project are complemented with an innovative program of public outreach, actively linking patients and society to the evolvement of this project. The GAMBA platform is going to implement a concept of spatiotemporal control of ...
Voir le projet